BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19464548)

  • 1. Saccharomyces cerevisiae as a vaccine against coccidioidomycosis.
    Capilla J; Clemons KV; Liu M; Levine HB; Stevens DA
    Vaccine; 2009 Jun; 27(27):3662-8. PubMed ID: 19464548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccharomyces as a vaccine against systemic candidiasis.
    Liu M; Clemons KV; Johansen ME; Martinez M; Chen V; Stevens DA
    Immunol Invest; 2012; 41(8):847-55. PubMed ID: 22686468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
    Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
    J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection.
    Liu M; Clemons KV; Bigos M; Medovarska I; Brummer E; Stevens DA
    Vaccine; 2011 Feb; 29(9):1745-53. PubMed ID: 21219976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against experimental aspergillosis by heat-killed yeast is not antibody dependent.
    Clemons KV; Martinez M; Chen V; Liu M; Yoon HJ; Stevens DA
    Med Mycol; 2014 May; 52(4):422-6. PubMed ID: 24625671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii.
    Majumder T; Liu M; Chen V; Martinez M; Alvarado D; Clemons KV; Stevens DA
    Mycopathologia; 2014 Oct; 178(3-4):189-95. PubMed ID: 25118873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-killed yeast protects diabetic ketoacidotic-steroid treated mice from pulmonary mucormycosis.
    Luo G; Gebremariam T; Clemons KV; Stevens DA; Ibrahim AS
    Vaccine; 2014 Jun; 32(29):3573-6. PubMed ID: 24814556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole glucan particles as a vaccine against murine aspergillosis.
    Clemons KV; Danielson ME; Michel KS; Liu M; Ottoson NC; Leonardo SM; Martinez M; Chen V; Antonysamy MA; Stevens DA
    J Med Microbiol; 2014 Dec; 63(Pt 12):1750-1759. PubMed ID: 25288643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-Killed Yeast as a Pan-Fungal Vaccine.
    Martinez M; Clemons KV; Stevens DA
    Methods Mol Biol; 2017; 1625():23-30. PubMed ID: 28584980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
    Kirkland TN; Raz E; Datta SK
    Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the protective subcellular coccidioidal T27K vaccine.
    Johnson SM; Kerekes KM; Lunetta JM; Pappagianis D
    Ann N Y Acad Sci; 2007 Sep; 1111():275-89. PubMed ID: 17363436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The public health need and present status of a vaccine for the prevention of coccidioidomycosis.
    Hector R; Rutherford GW
    Ann N Y Acad Sci; 2007 Sep; 1111():259-68. PubMed ID: 17344529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).
    Johnson SM; Lerche NW; Pappagianis D; Yee JL; Galgiani JN; Hector RF
    Ann N Y Acad Sci; 2007 Sep; 1111():290-300. PubMed ID: 17347333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
    Pappagianis D
    Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of myostatin-specific whole recombinant yeast Saccharomyces cerevisiae vaccine increases body weight and muscle composition in mice.
    Zhang T; Yang H; Wang R; Xu K; Xin Y; Ren G; Zhou G; Zhang C; Wang L; Zhang Z
    Vaccine; 2011 Oct; 29(46):8412-6. PubMed ID: 21840360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
    Pappagianis D
    Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
    Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
    Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.